ADMA Biologics (ADMA) investor relations material

Opening remarks and agenda

• The meeting was called to order by the CEO, who welcomed attendees to the virtual format and outlined the process for conducting official business.

• Legal and technical formalities were addressed to ensure the meeting was duly authorized, including the appointment of the Inspector of Election.

• The agenda included the introduction of directors, officers, and the independent accounting firm, as well as the presentation of proposals for shareholder consideration.

Board and executive committee updates

• Directors and officers were introduced, including new and continuing members, and representatives from the independent accounting firm were presented.

Shareholder proposals

• Three proposals were presented: election of Class I Directors, ratification of the independent accounting firm, and a non-binding advisory vote on executive compensation.